7Baggers

Thermo Fisher Scientific Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Inventory  
20200926 20201231 20210403 20210703 20211002 20211231 20220402 20220702 20221001 20221231 20230401 20230701 20230930 20231231 20240330 20240629 20240928 20241231 20250329 20250628 06.7513.520.252733.7540.547.25Billion

Thermo Fisher Scientific Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-28 2025-03-29 2024-12-31 2024-09-28 2024-06-29 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28 2019-12-31 2019-09-28 2019-06-29 2019-03-30 2018-12-31 2018-09-29 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-07-01 2017-04-01 2016-12-31 2016-10-01 2016-07-02 2016-04-02 2015-12-31 2015-09-26 2015-06-27 2015-03-28 2012-12-31 2011-12-31 2010-12-31 2009-12-31 
                                                
  assets                                              
  current assets:                                              
  cash and cash equivalents4,576,000,000 4,134,000,000 4,009,000,000 4,645,000,000 7,073,000,000 5,499,000,000 8,077,000,000 6,151,000,000 3,133,000,000 3,482,000,000 8,524,000,000 2,919,000,000 1,888,000,000 2,752,000,000 4,477,000,000 12,027,000,000 7,023,000,000 5,583,000,000 10,325,000,000 7,540,000,000 5,818,000,000 2,981,000,000 2,399,000,000 1,273,000,000 2,288,000,000 1,106,000,000 2,103,000,000 1,098,000,000 937,000,000 950,000,000 1,335,000,000 741,100,000 611,000,000 713,300,000 786,200,000 1,970,000,000 663,100,000 826,800,000 452,100,000 503,400,000 768,400,000 864,600,000 851,000,000    
  short-term investments1,814,000,000 1,813,000,000 1,561,000,000 2,000,000,000 1,750,000,000 1,751,000,000                                   2,000,000 8,400,000     
  accounts receivable, less allowances8,594,000,000 8,455,000,000 8,191,000,000 8,255,000,000 7,943,000,000 7,931,000,000 8,221,000,000 8,370,000,000 8,019,000,000 7,922,000,000 8,115,000,000 7,671,000,000 7,745,000,000 7,889,000,000 7,977,000,000 5,557,000,000 5,476,000,000 5,554,000,000 5,741,000,000 5,186,000,000 4,478,000,000 4,508,000,000 4,349,000,000 4,384,000,000 4,129,000,000 4,155,000,000 4,136,000,000 3,852,000,000 3,911,000,000 3,990,000,000 3,879,000,000 3,657,000,000 3,258,300,000 3,096,500,000 3,048,500,000 2,895,100,000 2,709,100,000 2,668,300,000 2,544,900,000 2,543,900,000 2,631,000,000 2,538,000,000 1,804,900,000    
  inventories5,559,000,000 5,224,000,000 4,978,000,000 5,430,000,000 5,198,000,000 5,133,000,000 5,088,000,000 5,404,000,000 5,655,000,000 5,664,000,000 5,634,000,000 5,722,000,000 5,668,000,000 5,483,000,000 5,051,000,000 4,906,000,000 4,625,000,000 4,342,000,000 4,029,000,000 3,829,000,000 3,648,000,000 3,454,000,000 3,370,000,000 3,308,000,000 3,209,000,000 3,124,000,000 3,005,000,000 2,982,000,000 2,866,000,000 2,891,000,000 2,971,000,000 3,125,500,000 2,422,200,000 2,327,100,000 2,213,300,000 2,390,900,000 2,086,300,000 2,154,900,000 1,991,700,000 1,987,200,000 1,962,300,000 1,898,800,000 1,443,300,000 -32,500,000 -27,900,000 108,200,000 
  contract assets1,441,000,000 1,366,000,000 1,435,000,000 1,541,000,000 1,487,000,000 1,422,000,000 1,443,000,000 1,465,000,000 1,467,000,000 1,375,000,000 1,312,000,000 1,248,000,000 1,147,000,000 1,064,000,000 968,000,000 808,000,000 804,000,000 783,000,000 731,000,000 697,000,000 686,000,000 658,000,000 603,000,000                        
  other current assets2,599,000,000 2,387,000,000 1,964,000,000 1,911,000,000 2,025,000,000 1,904,000,000 1,760,000,000 1,702,000,000 1,721,000,000 1,766,000,000 1,644,000,000 1,739,000,000 1,652,000,000 1,588,000,000 1,640,000,000 1,426,000,000 1,332,000,000 1,423,000,000 1,131,000,000 982,000,000 1,145,000,000 1,137,000,000 1,172,000,000 1,549,000,000 1,597,000,000 1,554,000,000 1,381,000,000 1,229,000,000 1,230,000,000 1,217,000,000 804,000,000 768,300,000 746,100,000 684,200,000 594,700,000 948,400,000 872,500,000 889,000,000 752,500,000 728,100,000 589,400,000 571,300,000 549,300,000    
  total current assets24,584,000,000 23,378,000,000 22,137,000,000 23,783,000,000 25,476,000,000 23,640,000,000 24,589,000,000 23,092,000,000 19,995,000,000 20,209,000,000 25,229,000,000 19,299,000,000 18,100,000,000 18,776,000,000 20,113,000,000 24,724,000,000 19,260,000,000 17,685,000,000 21,957,000,000 18,234,000,000 15,775,000,000 12,738,000,000 11,893,000,000 10,514,000,000 11,223,000,000 9,939,000,000 10,625,000,000 9,566,000,000 9,474,000,000 9,588,000,000 9,421,000,000 8,844,000,000 7,452,500,000 7,248,100,000 7,021,000,000 8,204,400,000 6,331,000,000 6,539,000,000 5,741,200,000 6,025,900,000 6,236,600,000 6,180,500,000     
  property, plant and equipment9,635,000,000 9,331,000,000 9,306,000,000 9,412,000,000 9,282,000,000 9,324,000,000 9,448,000,000 9,167,000,000 9,292,000,000 9,354,000,000 9,280,000,000 8,628,000,000 8,529,000,000 8,448,000,000 8,333,000,000 7,049,000,000 6,560,000,000 6,133,000,000 5,912,000,000 5,180,000,000 4,887,000,000 4,736,000,000 4,749,000,000 4,420,000,000 4,394,000,000 4,192,000,000 4,165,000,000 3,978,000,000 3,952,000,000 4,059,000,000 4,047,000,000 3,931,600,000 2,599,700,000 2,563,300,000 2,577,800,000 2,599,300,000 2,451,600,000 2,483,100,000 2,448,800,000 2,392,200,000       
  acquisition-related intangible assets15,148,000,000 15,323,000,000 15,533,000,000 16,262,000,000 15,519,000,000 16,048,000,000 16,670,000,000 17,091,000,000 17,437,000,000 17,972,000,000 17,442,000,000 17,813,000,000 18,578,000,000 19,378,000,000 20,113,000,000 11,927,000,000 12,390,000,000 12,831,000,000 12,685,000,000 12,870,000,000 13,170,000,000 13,543,000,000 14,014,000,000 14,311,000,000 14,863,000,000 14,489,000,000 14,978,000,000 15,219,000,000 15,680,000,000 16,393,000,000 16,684,000,000 17,029,600,000 13,575,600,000 13,821,700,000 13,969,000,000 14,522,400,000 12,842,200,000 13,237,800,000 12,758,300,000 13,015,100,000 13,383,700,000 13,622,500,000 7,804,500,000    
  other assets4,615,000,000 4,516,000,000 4,492,000,000 4,180,000,000 4,377,000,000 4,241,000,000 3,999,000,000 4,124,000,000 4,108,000,000 3,983,000,000 4,007,000,000 4,308,000,000 4,306,000,000 4,424,000,000 4,640,000,000 2,991,000,000 2,584,000,000 2,459,000,000 2,457,000,000 1,995,000,000 2,061,000,000 2,057,000,000 2,011,000,000 1,860,000,000 1,733,000,000 1,740,000,000 1,117,000,000 1,173,000,000 1,177,000,000 1,178,000,000 1,227,000,000 1,051,200,000 1,040,400,000 1,020,200,000 1,011,900,000 1,104,600,000 1,081,800,000 1,060,300,000 1,113,100,000 967,600,000 940,300,000 937,200,000 604,400,000 -124,000,000 -81,300,000 -18,400,000 
  goodwill47,249,000,000 46,493,000,000 45,853,000,000 46,726,000,000 43,843,000,000 43,843,000,000 44,020,000,000 43,583,000,000 43,273,000,000 43,140,000,000 41,196,000,000 40,488,000,000 41,066,000,000 41,721,000,000 41,924,000,000 26,909,000,000 26,904,000,000 26,823,000,000 26,041,000,000 25,782,000,000 25,700,000,000 25,614,000,000 25,714,000,000 25,624,000,000 25,757,000,000 25,236,000,000 25,347,000,000 25,142,000,000 25,120,000,000 25,362,000,000 25,290,000,000 25,128,900,000 21,845,500,000 21,560,300,000 21,327,800,000 21,580,000,000 19,546,800,000 19,632,500,000 18,827,600,000 18,746,300,000 18,806,900,000 18,732,900,000 12,474,500,000    
  total assets101,230,000,000 99,041,000,000 97,321,000,000 100,364,000,000 98,496,000,000 97,095,000,000 98,726,000,000 97,057,000,000 94,105,000,000 94,658,000,000 97,154,000,000 90,536,000,000 90,579,000,000 92,747,000,000 95,123,000,000 73,600,000,000 67,698,000,000 65,931,000,000 69,052,000,000 64,061,000,000 61,593,000,000 58,688,000,000 58,381,000,000 56,729,000,000 57,970,000,000 55,596,000,000 56,232,000,000 55,078,000,000 55,403,000,000 56,580,000,000 56,669,000,000 55,985,300,000 46,513,700,000 46,213,600,000 45,907,500,000 48,010,700,000 42,253,400,000 42,952,700,000 40,889,000,000 41,147,100,000 41,774,400,000 41,857,300,000     
  liabilities, redeemable noncontrolling interest and equity                                              
  current liabilities:                                              
  short-term obligations and current maturities of long-term obligations2,214,000,000 2,819,000,000 2,214,000,000 4,116,000,000 5,121,000,000 4,451,000,000 3,609,000,000 4,795,000,000 4,814,000,000 6,122,000,000 5,579,000,000 1,010,000,000 1,010,000,000 1,866,000,000 2,537,000,000 19,000,000 4,000,000 4,000,000 2,628,000,000 2,000,000 675,000,000 738,000,000 676,000,000 661,000,000 2,377,000,000 1,336,000,000 1,271,000,000 1,014,000,000 1,711,000,000 2,814,000,000 2,135,000,000 2,762,300,000 1,540,400,000 1,882,400,000 1,255,500,000 1,972,100,000 2,515,900,000 3,383,000,000 1,052,800,000 3,034,000,000 3,359,800,000 4,160,600,000 93,100,000    
  accounts payable2,980,000,000 3,049,000,000 3,079,000,000 2,606,000,000 2,547,000,000 2,555,000,000 2,872,000,000 2,508,000,000 2,423,000,000 2,798,000,000 3,381,000,000 2,471,000,000 2,586,000,000 2,667,000,000 2,867,000,000 2,301,000,000 2,098,000,000 2,146,000,000 2,175,000,000 1,703,000,000 1,385,000,000 1,599,000,000 1,920,000,000 1,659,000,000 1,391,000,000 1,462,000,000 1,615,000,000 1,344,000,000 1,359,000,000 1,354,000,000 1,428,000,000 1,123,800,000 982,200,000 1,031,000,000 926,200,000 941,700,000 846,500,000 853,000,000 822,200,000 783,300,000 819,000,000 827,600,000 641,400,000 31,400,000 2,500,000 -44,900,000 
  accrued payroll and employee benefits1,518,000,000 1,419,000,000 1,988,000,000 1,823,000,000 1,495,000,000 1,314,000,000 1,596,000,000 1,460,000,000 1,310,000,000 1,307,000,000 2,095,000,000 1,864,000,000 1,722,000,000 1,634,000,000 2,427,000,000 1,816,000,000 1,492,000,000 1,314,000,000 1,916,000,000 1,538,000,000 1,184,000,000 755,000,000 1,010,000,000 883,000,000 809,000,000 704,000,000 982,000,000 817,000,000 755,000,000 643,000,000 918,000,000 771,100,000 612,600,000 520,800,000 708,700,000 611,200,000 521,600,000 421,200,000 598,200,000 549,300,000 478,500,000 486,900,000 388,000,000    
  contract liabilities2,805,000,000 2,866,000,000 2,852,000,000 2,663,000,000 2,591,000,000 2,632,000,000 2,689,000,000 2,547,000,000 2,590,000,000 2,662,000,000 2,601,000,000 2,567,000,000 2,722,000,000 2,871,000,000 2,655,000,000 1,442,000,000 1,470,000,000 1,396,000,000 1,271,000,000 1,047,000,000 975,000,000 938,000,000 916,000,000 943,000,000 1,062,000,000 967,000,000 809,000,000 797,000,000 816,000,000 909,000,000                 
  other accrued expenses3,200,000,000 3,022,000,000 3,199,000,000 3,393,000,000 3,019,000,000 2,985,000,000 3,246,000,000 2,848,000,000 2,975,000,000 2,995,000,000 3,354,000,000 3,206,000,000 2,957,000,000 3,032,000,000 2,950,000,000 2,175,000,000 1,861,000,000 2,135,000,000 2,314,000,000 1,938,000,000 1,794,000,000 1,470,000,000 1,675,000,000 1,698,000,000 1,870,000,000 1,429,000,000 1,470,000,000 1,224,000,000 1,339,000,000 1,352,000,000 1,848,000,000 1,501,100,000 1,308,600,000 1,247,600,000 1,324,100,000 1,219,000,000 1,263,900,000 1,249,400,000 1,143,700,000 996,200,000 1,067,800,000 1,013,900,000 774,300,000    
  total current liabilities12,718,000,000 13,174,000,000 13,332,000,000 14,601,000,000 14,772,000,000 13,937,000,000 14,012,000,000 14,158,000,000 14,112,000,000 15,884,000,000 17,010,000,000 11,118,000,000 10,997,000,000 12,070,000,000 13,436,000,000 7,753,000,000 6,925,000,000 6,995,000,000 10,304,000,000 6,228,000,000 6,013,000,000 5,500,000,000 6,197,000,000 5,844,000,000 7,509,000,000 5,898,000,000 6,147,000,000 5,196,000,000 5,980,000,000 7,072,000,000 7,048,000,000 7,031,300,000 5,075,800,000 5,302,900,000 4,865,800,000 5,259,900,000 5,528,200,000 6,322,800,000 4,147,300,000 5,735,100,000 6,100,400,000 6,861,000,000     
  deferred income taxes624,000,000 1,041,000,000 1,268,000,000 1,123,000,000 1,516,000,000 1,811,000,000 1,922,000,000 2,620,000,000 2,842,000,000 2,976,000,000 2,849,000,000 3,140,000,000 3,327,000,000 3,493,000,000 3,837,000,000 1,465,000,000 1,632,000,000 1,885,000,000 1,794,000,000 1,528,000,000 1,750,000,000 2,137,000,000 2,192,000,000 2,001,000,000 1,936,000,000 2,145,000,000 2,265,000,000 2,550,000,000 2,599,000,000 2,606,000,000 2,766,000,000 3,134,600,000 2,320,400,000 2,463,400,000 2,557,400,000 2,715,000,000 2,481,500,000 2,694,000,000 2,622,600,000 3,031,700,000 3,134,900,000 3,222,900,000 2,047,200,000    
  other long-term liabilities4,270,000,000 3,971,000,000 3,989,000,000 4,343,000,000 4,391,000,000 4,567,000,000 4,642,000,000 4,326,000,000 4,042,000,000 4,230,000,000 4,238,000,000 4,401,000,000 4,534,000,000 4,664,000,000 4,540,000,000 3,984,000,000 3,514,000,000 3,352,000,000 3,340,000,000 3,390,000,000 3,317,000,000 3,261,000,000 3,241,000,000 3,137,000,000 3,133,000,000 3,048,000,000 2,515,000,000 2,682,000,000 2,670,000,000 2,657,000,000 2,569,000,000 1,887,200,000 1,470,200,000 1,463,700,000 1,572,600,000 1,436,800,000 1,347,900,000 1,358,500,000 1,295,000,000 1,252,200,000 1,195,600,000 1,162,400,000 808,200,000    
  long-term obligations33,015,000,000 31,370,000,000 29,061,000,000 31,197,000,000 30,284,000,000 31,157,000,000 31,308,000,000 30,489,000,000 29,194,000,000 29,135,000,000 28,909,000,000 28,150,000,000 29,250,000,000 31,389,000,000 32,333,000,000 21,688,000,000 18,773,000,000 18,641,000,000 19,107,000,000 21,091,000,000 20,638,000,000 19,231,000,000 17,076,000,000 16,392,000,000 16,663,000,000 16,812,000,000 17,719,000,000 17,760,000,000 17,709,000,000 18,122,000,000 18,873,000,000 19,230,400,000 15,255,700,000 15,188,400,000 15,372,400,000 16,940,400,000 11,631,900,000 11,653,000,000 11,473,900,000 10,277,900,000 10,663,700,000 10,696,200,000 7,031,200,000    
  redeemable noncontrolling interest126,000,000 128,000,000 120,000,000 127,000,000 115,000,000 119,000,000 118,000,000 118,000,000 113,000,000 123,000,000 116,000,000 119,000,000 117,000,000 113,000,000 122,000,000                                
  equity:                                              
  thermo fisher scientific inc. shareholders’ equity:                                              
  preferred stock, 100 par value, 50,000 shares authorized; none issued                                              
  common stock444,000,000 444,000,000 444,000,000 444,000,000 443,000,000 443,000,000 442,000,000 442,000,000 441,000,000 441,000,000 441,000,000 440,000,000 440,000,000 440,000,000 439,000,000 439,000,000 438,000,000 438,000,000 437,000,000 437,000,000 436,000,000 435,000,000 434,000,000 434,000,000 433,000,000 433,000,000 432,000,000 431,000,000 430,000,000 429,000,000 428,000,000 428,000,000 416,900,000 416,400,000 415,100,000 415,000,000 414,000,000 413,300,000 411,900,000    413,500,000    
  capital in excess of par value18,232,000,000 18,111,000,000 17,962,000,000 17,831,000,000 17,649,000,000 17,482,000,000 17,286,000,000 17,165,000,000 17,030,000,000 16,889,000,000 16,743,000,000 16,596,000,000 16,467,000,000 16,292,000,000 16,174,000,000 15,960,000,000 15,826,000,000 15,684,000,000 15,579,000,000 15,467,000,000 15,334,000,000 15,186,000,000 15,064,000,000 14,964,000,000 14,887,000,000 14,771,000,000 14,621,000,000 14,526,000,000 14,408,000,000 14,319,000,000 14,177,000,000 14,112,000,000 12,328,200,000 12,252,000,000 12,139,600,000 12,097,100,000 12,016,900,000 11,918,800,000 11,801,200,000 11,732,800,000 11,669,300,000 11,607,300,000 10,501,100,000    
  retained earnings55,901,000,000 54,447,000,000 53,102,000,000 51,421,000,000 49,940,000,000 48,542,000,000 47,364,000,000 45,869,000,000 44,289,000,000 43,064,000,000 41,910,000,000 40,452,000,000 39,074,000,000 37,528,000,000 35,431,000,000 33,876,000,000 32,076,000,000 30,350,000,000 28,116,000,000 25,705,000,000 23,860,000,000 22,791,000,000 22,092,000,000 21,165,000,000 20,482,000,000 19,439,000,000 18,696,000,000 17,866,000,000 17,226,000,000 16,542,000,000 15,914,000,000 15,445,800,000 14,972,300,000 14,419,400,000 13,926,900,000 13,356,500,000 12,942,500,000 12,485,200,000 12,142,300,000 11,599,700,000 11,183,700,000 10,732,100,000 7,697,300,000    
  treasury stock-21,269,000,000 -21,269,000,000 -19,226,000,000 -18,227,000,000 -18,187,000,000 -18,186,000,000 -15,133,000,000 -15,121,000,000 -15,084,000,000 -15,083,000,000 -12,017,000,000 -11,011,000,000 -10,964,000,000 -10,961,000,000 -8,922,000,000 -8,911,000,000 -8,856,000,000 -8,852,000,000 -6,818,000,000 -6,815,000,000 -6,766,000,000 -6,765,000,000 -5,236,000,000                 -1,007,300,000 -988,700,000 -988,200,000 -2,996,800,000    
  accumulated other comprehensive income/-2,797,000,000 -2,343,000,000 -2,697,000,000 -2,477,000,000 -2,413,000,000 -2,764,000,000 -3,224,000,000 -3,027,000,000 -2,924,000,000 -3,054,000,000                                     
  total thermo fisher scientific inc. shareholders’ equity50,512,000,000 49,390,000,000 49,584,000,000 48,992,000,000 47,432,000,000 45,516,000,000 46,735,000,000 45,328,000,000 43,752,000,000 42,257,000,000 43,978,000,000 43,549,000,000 42,293,000,000 40,956,000,000 40,793,000,000                                
  noncontrolling interests-35,000,000 -33,000,000 -33,000,000 -20,000,000 -12,000,000 -12,000,000 -11,000,000 18,000,000 50,000,000 53,000,000 54,000,000 59,000,000 61,000,000 62,000,000 62,000,000                                
  total equity50,476,000,000 49,357,000,000 49,551,000,000 48,972,000,000 47,419,000,000 45,504,000,000 46,724,000,000 45,346,000,000 43,802,000,000 42,310,000,000 44,032,000,000 43,608,000,000 42,354,000,000 41,018,000,000 40,855,000,000                                
  total liabilities, redeemable noncontrolling interest and equity101,230,000,000 99,041,000,000 97,321,000,000 100,364,000,000 98,496,000,000 97,095,000,000 98,726,000,000 97,057,000,000 94,105,000,000 94,658,000,000 97,154,000,000 90,536,000,000 90,579,000,000 92,747,000,000 95,123,000,000                                
  commitments and contingencies                                              
  accumulated other comprehensive items          -3,099,000,000 -2,928,000,000 -2,724,000,000 -2,343,000,000 -2,329,000,000 -2,654,000,000 -2,630,000,000 -2,562,000,000 -2,807,000,000 -2,970,000,000 -2,989,000,000 -3,088,000,000 -2,679,000,000                 -1,886,400,000 -1,595,100,000 -1,846,600,000 -150,400,000    
  liabilities and shareholders' equity                                              
  shareholders' equity:                                              
  total shareholders' equity               38,710,000,000 36,854,000,000 35,058,000,000 34,507,000,000 31,824,000,000 29,875,000,000 28,559,000,000 29,675,000,000 29,355,000,000 28,729,000,000 27,693,000,000 27,586,000,000 26,890,000,000 26,445,000,000 26,123,000,000 25,413,000,000 24,701,800,000 22,391,600,000 21,795,200,000 21,539,300,000 21,658,600,000 21,263,900,000 20,924,400,000 21,350,200,000 20,850,200,000 20,679,800,000 19,914,800,000     
  total liabilities and shareholders' equity               73,600,000,000 67,698,000,000 65,931,000,000 69,052,000,000 64,061,000,000 61,593,000,000 58,688,000,000 58,381,000,000 56,729,000,000 57,970,000,000 55,596,000,000 56,232,000,000 55,078,000,000 55,403,000,000 56,580,000,000 56,669,000,000 55,985,300,000 46,513,700,000 46,213,600,000 45,907,500,000 48,010,700,000 42,253,400,000 42,952,700,000 40,889,000,000 41,147,100,000 41,774,400,000 41,857,300,000     
  deferred revenue                              719,000,000 747,300,000 542,100,000 538,900,000 485,900,000 492,200,000 358,500,000 360,500,000 317,900,000 320,900,000 334,300,000 332,900,000 196,500,000    
  refundable income taxes                           405,000,000 530,000,000 540,000,000 432,000,000 552,100,000 414,900,000 427,000,000 378,300,000            
  accrued income taxes                               125,700,000 89,900,000 82,200,000 165,400,000 23,700,000 21,800,000 55,700,000 212,500,000 51,400,000 41,000,000 39,100,000     
  deferred tax assets                                       263,300,000 283,500,000 299,400,000 182,000,000    
  408,461,670 shares issued                                       411,400,000 410,600,000 410,200,000     
  property, plant and equipment, at cost                                        2,406,900,000 2,384,200,000 1,726,400,000    
  short-term investments, at quoted market value                                          4,300,000    
  operating activities                                              
  net income                                           1,329,900,000 1,035,600,000 850,300,000 
  income from discontinued operations                                           -5,500,000   
  (gain) loss on disposal of discontinued operations                                           -304,800,000   
  income from continuing operations                                           1,019,600,000 1,033,100,000 851,300,000 
  adjustments to reconcile income from continuing operations to net cash from operating activities:                                              
  depreciation and amortization                                           863,500,000 770,000,000 787,300,000 
  change in deferred income taxes                                           -123,100,000 -272,400,000 -248,600,000 
  non-cash stock-based compensation                                           80,200,000 83,100,000 68,100,000 
  non-cash interest expense on convertible debt                                           1,400,000 9,100,000 22,500,000 
  non-cash charges for sale of inventories revalued at the date of acquisition                                           69,500,000 11,400,000 3,700,000 
  tax benefits from stock-based compensation awards                                           -16,900,000 -12,800,000 -2,600,000 
  other non-cash expenses                                           49,100,000 63,900,000 63,800,000 
  changes in assets and liabilities, excluding the effects of acquisitions and dispositions:                                              
  accounts receivable                                           -107,300,000 -89,500,000 127,300,000 
  other liabilities                                           -7,200,000 33,700,000 -16,300,000 
  contributions to retirement plans                                           -25,300,000 -24,400,000 -41,100,000 
  net cash from continuing operations                                           1,678,400,000 1,498,500,000 1,660,300,000 
  net cash from discontinued operations                                           12,600,000 -700,000 -1,100,000 
  net cash from operating activities                                           1,691,000,000 1,497,800,000 1,659,200,000 
  investing activities                                              
  acquisitions, net of cash acquired                                           -5,698,600,000 -606,200,000 -637,300,000 
  purchase of property, plant and equipment                                           -266,500,000 -265,500,000 -207,500,000 
  proceeds from sale of property, plant and equipment                                           8,200,000 10,200,000 13,400,000 
  proceeds from sale of investments                                           19,500,000   
  proceeds from sale of businesses, net of cash divested                                           13,800,000  4,400,000 
  proceeds from derivative instruments related to phadia acquisition                                           27,600,000   
  other investing activities                                           -6,000,000 -1,500,000  
  net cash from discounted operations                                           759,800,000   
  net cash from investing activities                                           -5,142,200,000 -858,900,000 -829,500,000 
  financing activities                                              
  net proceeds from issuance of long-term debt                                           4,254,100,000 741,400,000 748,200,000 
  increase in commercial paper                                           899,300,000   
  settlement of convertible debt                                           -452,000,000 -600,800,000 -615,500,000 
  redemption and repayment of long-term obligations                                           -1,400,000 -505,400,000 -311,500,000 
  purchases of company common stock                                           -1,337,500,000 -1,012,500,000 -414,600,000 
  net proceeds from issuance of company common stock                                           158,100,000 77,300,000 54,400,000 
  increase in short-term notes payable                                           9,200,000   
  other financing activities                                           3,900,000   
  net cash from financing activities                                           3,550,600,000 -1,295,100,000 -557,500,000 
  exchange rate effect on cash                                           -200,000   
  increase in cash and cash equivalents                                           99,200,000 -647,000,000 283,600,000 
  cash and cash equivalents at beginning of period                                           917,100,000   
  cash and cash equivalents at end of period                                           1,016,300,000   
  see note 13 for supplemental cash flow information.                                              
  gain on disposal of discontinued operations                                            -2,500,000 1,000,000 
  decrease in short-term notes payable                                            -7,900,000 -21,100,000 
  exchange rate effect on cash of continuing operations                                            9,200,000 11,400,000 
  cash and cash equivalents at beginning of year                                            1,564,100,000 1,280,500,000 
  cash and cash equivalents at end of year                                            917,100,000 1,564,100,000 
  purchase of available-for-sale investments                                              
  proceeds from sale of available-for-sale investments                                             800,000 
  distribution from retirement trust to fund disbursements                                             400,000 
  collection of notes receivable                                             300,000 
  increase in other assets                                             -4,000,000 

We provide you with 20 years of balance sheets for Thermo Fisher Scientific stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Thermo Fisher Scientific. Explore the full financial landscape of Thermo Fisher Scientific stock with our expertly curated balance sheets.

The information provided in this report about Thermo Fisher Scientific stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.